Destin, FL CME Conference

This expression originated from theatre, where performers had to literally face the music, the orchestra, and overcome stage fright. Patients with Acne and Rosacea are forced to Face the Music daily, as are those with diseases of the Hair and Nails. Additionally, patients with Cysts and Hidradenitis struggle with pain and scarring. Learn about the new guidelines and drugs which will allow your patients to look and feel their best! This session will also discuss the quiet part out loud by incorporating cultural sensitivity into your interactions with Sexual-Gender Diverse patients, up to date approaches to STDs, and enhanced safety in pregnancy.

How do you determine if the blotchy red rash on the hands of a newlywed just back from Margueritaville is from contact with sunscreen, limes, or his new wedding band? How can you tell if a rash is localized to the skin or a Cutaneous Manifestation of underlying Systemic Disease? What are the new guidelines to help patients who suffer with Atopic Dermatitis, The Itch that Rashes? How can you help your patients with Psoriasis gain control over this complex disease which affects them both inside and out? Sherlock Holmes, the infamous 19th century sleuth, was a master of observation and deductive reasoning. We can learn from his investigative skills and apply them to our assessment of skin rashes and how to manage them.

Do you have patients taking Biologics and JAK inhibitors prescribed by Dermatology, Rheumatology, or Gastroenterology but have been afraid to ask how they work? Do you have patients taking drugs prescribed by their Oncologist or Transplant surgeon which manage one disease only to increase the risk for others? This session will allow you to earn Pharma CMEs in keeping with clinical context so you can associate appropriate treatments for various skin diseases and increase your familiarity with new drugs. And Yes!! There ARE Dermatology Emergencies! We will review various rashes, potential toxicities and appropriate management of Drug Reactions which can erupt from even common medications.

Being able to identify harmless spots on the skin will not only allow you to provide reassurance to your patients when evaluating Benign Lesions but will also bring your attention to growths which have abnormal features. As the numbers of all types of Skin Cancers continue to increase, it is increasingly important for non-Dermatology providers to be able to identify suspicious lesions. This session will also provide you with multiple examples of worrisome, pigmented lesions which will increase your familiarity with atypical Moles. Early detection can absolutely reduce the morbidity and mortality of Melanoma!

This session will focus on non-traumatic neck pain and cervical radiculopathy. The participants will learn various exam techniques through video and a strong understanding of the neurologic anatomy associated with neck complaints. Specialized testing for cervical myelopathy will be addressed as well as a physical exam for the non-trauma neck pain patient. A brief review of the treatment modalities and radiographic findings will also be demonstrated. This presentation will assist the clinician in understanding urgent from routine pathology.

This session will address a widespread problem for many generations of patients, shoulder pain. Contrary to many patients’ beliefs, there are numerous pathologies that can affect the shoulder besides rotator cuff injuries. This presentation will assist the clinician in understanding common presentations for shoulder pain with a strong emphasis on physical exam techniques. The exam techniques will better allow the provider to understand the pathology of the complex shoulder joint. Numerous videos will be used in this presentation to teach many of the commonly used specialized shoulder examination tests and what they may imply.

Chest X-ray (CXR) is the most ordered radiologic diagnostic, yet it can be one of the most complex to understand. CXR combines organs, bones, soft tissue and comprises innumerable pathology of the cardiac, pulmonary, and gastric systems, to name a few. This presentation will break down CXR interpretation by first reviewing what is expected. Then, multiple diagramed studies will be used, and typical findings related to asthma, COPD, cardiomegaly, infiltrates, Covid, CHF, & pneumothorax. Finally, case studies will be used to enhance the learning process.

This session will be a “smorgasbord” of radiologic case studies. Numerous cases from a local emergency department will be reviewed, covering the common and not-so-common osseous diagnosis and treatment options. Topics will also include commonly diagnosed fractures, dislocations, and soft tissue abnormalities diagnosed with plain radiographs. This will be a fun participant interaction presentation.

An overview of the intersection of obesity, T2DM, and hypertension pathophysiology will set the stage for understanding how traditional and novel anti-obesity therapies impact these diseases and the cardiac implications.

Most primary care providers ask, “How can I add another disease to be treated to my already very busy schedule, especially one that is impacting so many of my patients?” This presentation will demonstrate through a case study how to integrate the treatment of obesity into primary care using evidence-based guideline treatment.

Today’s reality for pharmacology treatment of obesity on-label provides limited choices, including choices limited by cost. Experienced clinicians treating obesity recognize the value of on-label prescribing when available and appropriate but also look to off-label use of medications for obesity treatment. This presentation will briefly review current FDA-approved medicines approved for the long-term treatment of the chronic disease of obesity. The discussion will then move to the long-term use of FDA-approved short-term medications and medications known to support weight loss but do not have FDA approval for that purpose. Case studies will be utilized to demonstrate these situations.

Obesity is the most common chronic disease in the United States and is at the root of over 236 complications, including 14 obesity-related cancers. In this presentation, case studies and a review of treatment plans will be demonstrated in patients with multiple chronic diseases.

PCOS is one of the most common endocrine/metabolic disorders in females. Approximately 10% of reproductive aged females have PCOS, and approximately 10% of reproductive aged females have endometriosis. Yet both of these disorders are widely misunderstood, under-diagnosed, and under-treated. We'll examine the impact of these disorders on your patients, and dive into the different phenotypes and why both are often a missed diagnosis. Then we'll move on to options for treatment, including hormonal, non hormonal, and holistic measures for improvement in symptoms.

Time for sex ed for grown ups! Let's examine the role and function of the female sexual response cycle, how it's different from, but not the defunct version of, male sexuality. And how to appropriately counsel our patients when they ask us how to improve their low libido, or their pain with sex. We'll discuss options for creating a safe and empowering space for your patients to ask their burning questions and for you to feel confident in your answers! And the best part, we'll do all of this with science! No more shame in sexuality. This is general medicine and we can create a comfort and confidence in this facet of medicine for you. We'll review mechanisms of arousal and orgasm, and the pharmacologic and non pharmacologic interventions you can utilize in practice.

One hormone at a time. How many patients have asked you to check their hormones, because "something just isn't right" or "I keep gaining weight"? We're going to break it all down - hormones, perimenopause, menopause, The Women's Health Initiative (WHI), the up to date data on hormone risks and benefits so you can answer those seemingly unanswerable questions. The WHI still plagues both prescribers and patients with its longstanding effects on perceptions of hormones, so let's clarify what the data showed and what that means for your patients.

BV accounts for 40-50% of all cases of vaginitis, with yeast following closely behind. Yet little is known or undestood about these infections when they become recurrent. How does our vaginal microbiome play into this? Do probiotics help? What can we as providers do to help our patients who suffer with these recurrences? Leave today with increased understanding of diagnosis and treatment guidelines.